Cargando…
Suppressor PAQR3 associated with the clinical significance and prognosis in esophageal squamous cell carcinoma
Progestin and adipoQ receptor family member 3 (PAQR3) is a novel tumor suppressor; however, its function in esophageal cancer is not well understood. The present study explored the association between PAQR3, and the survival and clinical phenotype in patients with esophageal squamous cell carcinoma...
Autores principales: | Bai, Ge, Yang, Mei, Zheng, Chao, Zhang, Li, Eli, Mayinur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840698/ https://www.ncbi.nlm.nih.gov/pubmed/29552204 http://dx.doi.org/10.3892/ol.2018.8004 |
Ejemplares similares
-
PAQR3 Inhibits the Proliferation and Tumorigenesis in Esophageal Cancer Cells
por: Zhou, Fang, et al.
Publicado: (2017) -
Expression and prognosis analysis of PAQR5 in kidney cancer
por: Lu, Tao, et al.
Publicado: (2022) -
ATF3 functions as a novel tumor suppressor with prognostic significance in esophageal squamous cell carcinoma
por: Xie, Jian-Jun, et al.
Publicado: (2014) -
Decreased Tumor Suppressor Candidate 3 Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma
por: Yu, Xinshuang, et al.
Publicado: (2016) -
SOX2 amplification and chromosome 3 gain significantly impact prognosis in esophageal squamous cell carcinoma
por: Wang, Xin, et al.
Publicado: (2021)